You searched for Antibody candidate - Page 23 of 69

News and Trends 13 Feb 2020

French Partnership Deploys AI for Antibody Drug Discovery

…development — will help users identify a therapeutic target and select a candidate antibody that can enter production. OSE Immunotherapeutics hopes to deploy the partnership on fusion protein technology called…

February 13, 2020 - 2 minutesmins - By External Contributor

News and Trends 20 Jun 2023

Clearance for anti-tumor bispecific antibody trial

TG ImmunoPharma Co., Ltd. (TGI), which focuses on the development of novel immuno-oncology therapies, says the FDA has granted clearance for the clinical trial of TGI-6, its bispecific antibody. TGI-6…

June 20, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 15 Nov 2022

Biotheus enters agreement with Hansoh Pharma for bispecific antibody

…EGFR/MET bispecific antibody (also known as PM1080) in China, Hong Kong, Macao and Taiwan. Under the terms of the agreement, Hansoh will be granted by Biotheus the exclusive rights to…

November 15, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Oct 2016

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

…(ADCT) is a Swiss Biotech that develops antibody-drug conjugates (ADCs) for oncology applications. Its founder Auven Therapeutics and its partner AstraZeneca have participated in the biggest funding round of the…

October 19, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 5 Jun 2017

What Lies Ahead in Biotech for the UK’s Top Academic Entrepreneur?

…company, Cambridge Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after its team discovered the blockbuster therapeutic antibody, Humira, and became part of…

June 5, 2017 - 7 minutesmins - By Evelyn Warner

antibody drug conjugate adc small cancer treatment

News and Trends 12 Jan 2023

Ajinomoto and Exelixis to discover and develop novel ADCs to treat cancer

…Ajinomoto Co.’s proprietary site-specific bioconjugation and stable linker technologies compatible with commonly used antibody isotypes. AJICAP technology includes its “off-the-shelf” feature, allowing any therapeutic antibody at any stage of development…

January 12, 2023 - 2 minutesmins - By Jim Cornall

Interview 29 May 2017

Meet the Founder of the UK’s Best Biotech that Discovered Humira

…Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after it discovered the blockbuster therapeutic antibody, Humira, and became part of AstraZeneca in 2006…

May 29, 2017 - 9 minutesmins - By Evelyn Warner

ADCs that deliver: The secret lies in rigorous characterization

Antibody-drug conjugates (ADCs) represent an innovative class of potent anti-cancer agents. They combine the specificity of a monoclonal antibody with the potency of a cytotoxic drug, enabling targeted killing of…

September 17, 2024 - 7 minutesmins - By Ute Boronowsky

News and Trends 1 Dec 2016

Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer

…antibody-drug conjugate (ADC) candidate, MI130110, against fibrosarcoma and multiple myeloma. Which means the popular ADC field has managed to attract yet another company into what could be a major breakthrough…

December 1, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Jun 2016

German Biotech launches Phase II in a hot Target for Inflammation

InflaRx has treated the first patient in a new Phase II trial, which is studying the potential of its anti-complement antibody in avoiding immunological complications after complex cardiac surgery –…

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

large molecule manufacturing: Lonza woman working in laboratory

Large molecule manufacturing: addressing challenges with strategies for success

…the characteristics of the molecule. This panel of offerings covers a broad range of protein modalities that include antibody-based products, such as bispecific antibodies, Fc-Fusion proteins, and antibody fragments, and…

March 26, 2024 - 8 minutesmins - By Alexander Burik

News and Trends 24 Feb 2025

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

…but this time around, for the chronic respiratory illness idiopathic pulmonary fibrosis (IPF). The candidate MTX-463 is a human IgG1 antibody designed to neutralize WISP1-mediated fibrotic signaling in IPF. The…

February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

French Partnership Deploys AI for Antibody Drug Discovery

Clearance for anti-tumor bispecific antibody trial

Biotheus enters agreement with Hansoh Pharma for bispecific antibody

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

What Lies Ahead in Biotech for the UK’s Top Academic Entrepreneur?

Ajinomoto and Exelixis to discover and develop novel ADCs to treat cancer

Meet the Founder of the UK’s Best Biotech that Discovered Humira

ADCs that deliver: The secret lies in rigorous characterization

Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer

German Biotech launches Phase II in a hot Target for Inflammation

Large molecule manufacturing: addressing challenges with strategies for success

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!